Thursday, April 02, 2020 6:04:37 PM
We'll see how aggressive, or not, KVP wants to be with their counterclaim later this month.
(IN CHAMBERS) ORDER RE MOTION TO DISMISS ALL CLAIMS WITHOUT PREJUDICE (DKT. [112]) by Judge John A. Kronstadt: The Motion is GRANTED-IN-PART and DENIED-IN-PART: Endonovo is deemed bound by its proposed covenant not to sue KVP, as stated in its Motion, Docket No. 112 at page 5. Pursuant to Rule 41(a)(2), Endonovo's claims in this action shall be dismissed with prejudice. Pursuant to Rule 41(a)(2), KVP's counterclaims in this action shall be dismissed without prejudice. On or before 4/10/2020, the parties shall meet and confer regarding the form of a proposed final judgment. The form of proposed judgment shall be lodged on or before 4/17/2020. If KVP agrees to the form of the proposed judgment, it shall sign the proposed judgment with that language placed next to its signature. If KVP disputes the form of the proposed judgment, it shall file any objections on or before 4/22/2020. The Court will resolve any disputes andenter the corresponding judgment. Within 14 days of the entry of the judgment, KVP may file a motion requesting an award of attorney's fees.
Recent ENDV News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM